Preeclampsia

Summary of changes

Addition: Low BP medicines

Medicines

  • Adjustment of hydralazine dose to 5-10mg
  • Addition of caveat regarding IR nifedipine shortage 
  • Antihypertensive drug table added

Primary references

  1. American College of Obstetricians and Gynecologists (2020) Gestational Hypertension and Preeclampsia, Practice Bulletin No. 222, accessed 18 September 2022.

  2. Australian Medicines Handbook Pty Ltd (2021) Magnesium-sulfate (obstetric), Australian Medicines Handbook Pty Ltd, Adelaide.

  3. Norwitz ER and Funai EF (2021) Preeclampsia with severe features: Expectant management remote from term, accessed 11 January 2022.

  4. Queensland Clinical Guidelines (2021) Hypertension and pregnancy, Maternity and Neonatal Clinical Guidelines, accessed 17 September 2022.

  5. Society of Obstetric Medicine of Australia and New Zealand (2015) Guideline for the management of hypertensive disorders of pregnancy, accessed 18 September 2022.

  6. The Royal Women's Hospital (2020) Pre-eclampsia management, Clinical Guidelines, accessed 5 April 2022.